GHB use among Australians: Characteristics, use patterns and associated harm
Degenhardt L, Darke S, Dillon P. GHB use among Australians: characteristics, use patterns and associated harm. Drug and Alcohol Dependence 2002; 67: 89-94.
Gamma-hydroxybutyrate, gamma-butyrolactone, and 1,4-butanediol: A case report and review of the literature
Shannon M, Quang LS. Gamma-hydroxybutyrate, gamma-butyrolactone, and 1,4-butanediol: a case report and review of the literature. Pediatric Emergency Care 2000; 16: 435-440.
Gamma-hydroxybutyrate: An emerging drug of abuse that causes physical dependence
Galloway GP, Frederick SL, Staggers FE Jr, Gonzales M, Stalcup SA, Smith DE. Gamma-hydroxybutyrate: an emerging drug of abuse that causes physical dependence. Addiction 1997, 92: 89-96.
Gamma-hydroxybutyric acid and diazepam antagonize a rapid increase in GABA (A) receptors alpha (4) subunit mRNA abundance induced by ethanol withdrawal in cerebellar granule cells
Follesa P, Mancuso L, Biggio F et al. Gamma-hydroxybutyric acid and diazepam antagonize a rapid increase in GABA (A) receptors alpha (4) subunit mRNA abundance induced by ethanol withdrawal in cerebellar granule cells. Molecular Pharmacology 2003; 63: 896-907.
A case of withdrawal from the GHB precursors gamma-butyrolactone and 1,4-butanediol
Schneir AB, Ly BT, Clark RF. A case of withdrawal from the GHB precursors gamma-butyrolactone and 1,4-butanediol. Journal of Emergency Medicine 2001; 21: 31-33.
Gamma hydroxybutyrate (GHB) and gamma butyrolactone (GBL) withdrawal: Five case studies
McDaniel CH, Miotto KA. Gamma hydroxybutyrate (GHB) and gamma butyrolactone (GBL) withdrawal: five case studies. Journal of Psychoactive Drugs 2001; 33: 143-149.